Please login to the form below

Not currently logged in
Email:
Password:

idelalisib

This page shows the latest idelalisib news and features for those working in and with pharma, biotech and healthcare.

AbbVie and Roche to launch Venclexta within a week

AbbVie and Roche to launch Venclexta within a week

Venclexta will compete in the market with other new therapies for CLL, including Johnson &Johnson's first-in-class BTK inhibitor Imbruvica (ibrutinib) and Gilead Sciences' PI3 kinase inhibitor Zydelig (idelalisib),

Latest news

More from news
Approximately 4 fully matching, plus 30 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Consult

Consult is a bespoke data collection service designed to support marketing research clients in meeting those changing, increasingly focused research...

Latest intelligence

How digital content is helping physicians curb the opioid abuse epidemic
By Stephen Smith, PA, MDE...
SEO for the healthcare industry
Gaining online visibility in any disease area remains a challenge for marketers...
Junior Doctor contracts – PR winners and losers
GCI Health's Caroline Howley on who's winning the PR battle around the junior doctors' strike....

Infographics